tiprankstipranks
Trending News
More News >
Capricor Therapeutics (CAPR)
NASDAQ:CAPR

Compare Capricor Therapeutics (CAPR) vs. Competitors

Compare
1,275 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Capricor Therapeutics
$29.10
$1.67B
-12.77
102.65%
8 Buy
0 Hold
0 Sell
Strong Buy
Galectin Therapeutics
$5.71
$177.32M
-8.32
79.74%
1 Buy
0 Hold
0 Sell
Moderate Buy
Alector
$2.05
$226.24M
-1.12
57.69%
2 Buy
3 Hold
2 Sell
Hold
4D Molecular Therapeutics
$8.61
$439.55M
-3.10
129.60%
6 Buy
2 Hold
0 Sell
Strong Buy
Humacyte
$1.19
$151.10M
-3.93
-75.41%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CAPR
Capricor Therapeutics
29.10
15.82
119.13%
GALT
Galectin Therapeutics
2.75
1.10
66.67%
ALEC
Alector
2.05
0.68
49.64%
IMAB
FDMT
4D Molecular Therapeutics
8.61
4.68
119.08%
HUMA
Humacyte
0.78
-2.54
-76.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts